Cambridge, Massachusetts -- Medical technology company Emulate has raised $28 million in its second round of institutional venture capital funding.
Emulate says that it "emulates human biology to understand how diseases, medicines, chemicals and foods affect human health."
Investors in the round included NanoDimension, Cedars-Sinai Medical Center, OS Fund, Atel Ventures and individual investor Hanjorg Wyss.
The company said it would use the funding to accelerate its R&D efforts and expedite the launch of its products.
CEO James Coon has been with the firm since August 2014.